Schizophrenia trials recruiting in Oklahoma

All Schizophrenia trials nationally

Cities in Oklahoma

Recruiting trials in Oklahoma

• A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
  NCT06585787 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Oklahoma: Oklahoma City
• Artificial Intelligence to Measure Adherence to Oral Medication
  NCT04046497 · Phase: Phase 4 · Ages: 15 Years to 40 Years · Sex: All (male and female) · Oklahoma: Oklahoma City, Tulsa
• Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
  NCT07379827 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Oklahoma: Oklahoma City, Tulsa
• Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
  NCT07686263 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Oklahoma: Oklahoma City
• Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
  NCT05184335 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Oklahoma: Oklahoma City
• Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
  NCT06229210 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female) · Oklahoma: Oklahoma City